Clinical Trial Update: Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial update for Laser-Ranibizumab-Triamcinolone in diabetic macular edema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Laser-Ranibizumab-Triamcinolone

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2011-07-12